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Introduction
Pneumocystis carinii pneumonia remains a common, life-threatening opportunistic infection in immunocompromised patients. It is particularly prevalent among those with acquired immunodeficiency syndrome (AIDS), hematologic or solid malignancies, transplanted organs, or in patients receiving chronic immunosuppressive therapies, particularly corticosteroids (1-6). P. carinii pneumonia is characterized by filling of the alveolar spaces with distinctive protein-rich foamy exudates laden with organisms (7) . These proteinaceous exudates can be so marked as to mimic alveolar proteinosis (8) . The exact chemical nature of the alveolar exudates in P. carindi pneumonia is not fully defined, but prior studies indicate the presence of fibronectin, vitronectin, and surfactant components including surfactant protein D (SP-D)' (8) (9) (10) (11) (12) (13) .
Alveolar macrophages play a significant role in host defense by binding, phagocytizing, and degrading P. carini (14, 15) . Recent investigations demonstrate that lung surfactant may participate in the host-organism relationship during P. carini pneumonia and may modulate interaction of organisms with alveolar macrophages (12, 13, 16, 17) . Surfactant protein-A (SP-A) is present in enhanced amounts in the lower respiratory tract during P. carinii pneumonia and binds to the organism (12, 17) . Despite the presence of enhanced amounts of surfactant proteins in the lower respiratory tract during P. carinii pneumonia, physiologic studies suggest a relative deficiency of functional surface active material during pneumonia (18, 19) .
SP-D is a collagenous protein synthesized and secreted by alveolar type II cells and nonciliated bronchiolar cells (20) (21) (22) (23) . Structural studies demonstrate that SP-D possesses a calciumdependent lectin-binding domain sharing high sequence homology with the group Ill mammalian C-type lectins (24) (25) (26) . Several members of this family including bovine conglutinin, human mannose-binding protein, and SP-A are believed to participate in host defense against microorganisms (27) (28) (29) (30) (31) (32) . Previous studies indicate that SP-A binds to P. carinii and Staphylococcus aureus (12, 16, 17, 33) . Furthermore, SP-A enhances phagocytosis of particles through Fc receptor and complement receptor-I mechanisms (32) . SP-D has also been shown to interact with lipopolysaccharide present on Escherichia coli and to mediate agglutination of the organism (34) . Another C-type lectin, human mannose-binding protein, has been reported to function as an acute phase reactant and opsonin present in serum (29, 30) . Additional studies indicate that SP-D interacts with leukocytes. In particular, recent studies demonstrate that SP-D binds to alveolar macrophages (23) .
P. carindi possesses several carbohydrate-rich surface proteins capable of interacting with lectins and other glycoproteins (35) (36) (37) (38) (39) . In particular, P. carinji contains a major surface glycoprotein complex which has been variously termed gpA, gp 95, gpl2O, or major surface glycoprotein (40) (41) (42) (43) (44) (45) . Differences in the relative molecular mass of this complex have been related to the host species from which the P. carinii are derived (35) . Therefore, a number of investigators have adopted the nomenclature of gpA for this glycoprotein complex (44) (45) (46) (47) . Molecular studies indicate that gpA is encoded by a family of genes containing relatively conserved cysteine-rich regions (41, 42, 45, 46) . N-linked carbohydrate rich in mannose, glucose, and N-acetyl glucosamine residues represents approximately one-tenth of gpA's mass (35, 36, 48) . gpA is known to interact with several glycoproteins including concanavalin A, fibronectin, and SP-A and likely represents a major ligand recognized during the interactions of P. carinii with alveolar epithelial cells and macrophages (17, 39, 49, 50) . In view of the lectin-binding properties of SP-D and gpA, we hypothesized that SP-D interacts with P. carini through binding of gpA present on the organism.
The current investigation was therefore undertaken to accomplish the following goals: (a) to determine the extent and localization of SP-D in the lung during P. carinji pneumonia; (b) to investigate whether SP-D binds to P. carini organisms in vivo and to determine which components of the organism interact with SP-D; and (c) to determine the effect of SP-D on the interaction of P. carinii with alveolar macrophages. We present evidence that SP-D is present in enhanced amounts in the lower respiratory tract during P. carinji pneumonia and that SP-D specifically binds to gpA and modulates interaction of the organism with alveolar macrophages.
Methods
Materials. All organic chemicals were obtained from Sigma Chemical
Co. (St. Louis, MO) unless otherwise specified. "I-Bolton-Hunter reagent was purchased from New England Nuclear (Boston, MA). A polyclonal rabbit antiserum generated against rat SP-D has been described previously (21 (52) .
Preparation of P. carinii. All studies described in this report were approved by the institutional animal care committee. P. carinii pneumonia was induced in Harlan Sprague-Dawley rats by immunosuppression with dexamethasone as reported previously (53, 54) . Pathogen-free rats were provided with drinking water containing dexamethasone (2 mg/ liter), tetracycline hydrochloride (500 mg/liter), and nystatin (200,000 U/liter). After S d, rats were intratracheally inoculated with P. carinii (500,000 cysts) prepared by homogenizing lung from rats with pneumonia using a Stomacher blender (Tekmar Co., Cincinnati, OH). After 6 wk of additional immunosuppression, rats were killed, and whole lung lavage was performed with 50 ml of either HBSS or TBS containing 1 mM calcium as specified. P. carinii organisms were purified from this lavage by differential centrifugation (54, 55) . The recovered lavage fluids were initially centrifuged (400 g for 10 min) to remove inflammatory cells. Some cysts were present in these initial cellular pellets, as identified by Diff-Quik staining (Baxter Healthcare Corp., Dade Division, McGraw, IL), and were discarded along with the inflammatory cells. The supernatants containing predominantly suspended P. carinii organisms were recentrifuged (1,400 g for 30 min). The pellets resulting from the second centrifugation represent the P. carinii isolates used in these studies. These isolates were resuspended in 1 ml of HBSS, and duplicate 10-ml aliquots of this suspension were spotted onto glass slides, stained with Diff-Quick, and P. carinii quantified (54, 55) . Prior studies in our laboratory revealed that these isolates contain both trophozoite and cyst forms in a ratio of 9:1 (55 Immunohistochemistry. Immunohistochemistry was performed to evaluate the distribution of SP-D present in rat lung during P. carinii pneumonia. Lung specimens were fixed in 10% phosphate-buffered formalin and embedded in paraffin. Serial 5-,im sections were deparaffinized with xylene and graded alcohols and submitted to either standard hematoxylin and eosin staining, immunohistochemistry, or methenamine silver staining to visualize cysts. Tissue localization of SP-D was evaluated using a polyclonal rabbit antibody generated against purified rat SP-D (21) . The deparaffinized tissue sections were sequentially incubated for 30 min each in methanol containing 0.3% hydrogen peroxide to quench endogenous peroxidase activity, and 1.5% normal goat serum to reduce nonspecific binding of antibodies (56). Subsequently, the sections were incubated with primary antibody (10 jsg/ml) for 4 h. The sections were washed and reacted with biotinylated goat anti-rabbit IgG (2 ag/ml for 30 min; Dako Corp., Carpinteria, CA). The sections were next treated with peroxidase-conjugated streptavidin (2 pg/ml; Dako Corp.) for 30 min, and bound antibodies detected with 3-amino-9-ethylcarbazole substrate (AEC substrate; Dako Corp.) in the presence of 3% hydrogen peroxide for 15 min. Sections were counterstained with hematoxylin. To confirm the specificity of staining, semiserial sections were incubated with nonimmune IgG, and identical lung regions were examined.
Immunoelectron microscopy. To directly evaluate whether SP-D was bound to the surface of both P. carinii cysts and trophozoites, immunoelectron microscopy was performed. P. carinii were isolated from bronchoalveolar lavage (BAL) of moribund rats using TBS with 1 mM calcium to preserve surface-bound SP-D. Isolated organisms were fixed in periodate-lysine-paraformaldehyde buffer (57) Purification and radiolabeling ofSP-D. SP-D was isolated from the 10,000 g supernatant of lavage obtained from rats with silica-induced alveolar lipoproteinosis using affinity chromatography on maltosyl-agarose followed by gel filtration chromatography (58) (55) . The membranes were washed with TBS containing 0.05% Tween 20 and nonspecific binding sites blocked by incubation with TBS containing 1mg/ml BSA for 1 h at room temperature. Blocked membranes were incubated overnight in the same buffer containing 2 X l0 cpm '5I-SP-D/ml. In some experiments, an identical number of P. carinii was blotted with 1251-SP-D in the presence of EDTA (20 mM) or glucose (100 mM).
The next day, membranes were extensively washed in TBS, and bound SP-D was visualized by autoradiography. To confirm the identity of gpA in the P. carinii extracts, immunoblotting was also performed with antibody 5E12, a mouse IgM monoclonal antibody which recognizes gpA (51). The nitrocellulose membranes were incubated with mAb 5E12 (1:50 dilution) or with a similar concentration of nonimmune control immunoglobulin, washed and reincubated with a secondary peroxidaseconjugated goat anti-mouse IgM antibody (Sigma Chemical Co.). Bound antibodies were visualized by reaction of peroxidase with diaminobenzidine in the presence of H202-Interaction of purified gpA with SP-D. Prior studies indicate that gpA can be purified from P. carinii using polyacrylamide gel electrophoresis (11, 39) . P. carinii (1 X 108) were solubilized in 125 mM Tris, 4% SDS, 4% 2-mercaptoethanol, 0.002% bromophenol blue, and 20% glycerol, pH 7.4. From this extract, gpA was purified by continuous flow electrophoresis over a 10% polyacrylamide preparative tube gel (PrepCell Apparatus; Bio-Rad Laboratories, Hercules, CA). The gel was resolved over 48 h using 25 mA current and continuously eluted with 25 mM Tris Base, 192 mM glycine, and 0.1% SDS. Fractions were analyzed by SDS-PAGE and silver staining on 4-15% gradient resolving gels (Phast Gel System; Pharmacia LKB Biotechnology, Piscataway, NJ). Fractions containing the 120-kD complex were dialyzed and concentrated. Immunoblotting of the purified protein with monoclonal antibody 5E12 verified this material as gpA (51). To investigate SP-D binding to the purified gpA complex, we coated gpA (30 ,g/ml in 0.1 M NaHCO3) on 96-well break apart ELISA plates (Removawell Plates; Dynatech Laboratories Inc., Chantilly, VA) for 8 h at 22TC. The plates were washed and blocked by overnight incubation in TBS containing 1 mg/ ml BSA at 40C. The next day the plates were washed again and allowed to bind '"I-SP-D in TBS containing calcium (1 mM) and BSA (1 mg/ml) at the indicated concentrations. To assess the effects of various sugar ligands on SP-D binding to gpA, additional incubations were performed in the presence of glucose, mannose, or lactose (100 mM each). Nonspecific binding was determined in parallel by the presence of 20 mM EDTA which inhibited binding through SP-D's carbohydrate recognition domain.
Role of SP-D in P. carinii adherence to alveolar macrophages. We quantified the attachment of P. carinii to cultured alveolar macrophages in the presence or absence of antibody to SP-D or with the addition of purified SP-D. Adherence of P. carinii to alveolar macrophages was assayed by 5'Cr-labeling the organisms (60, 61). P. carini were isolated from rats with TBS containing 1 mM calcium to prevent loss of surfacebound SP-D. The organisms were radiolabeled by incubation for 8 h at 370C in 2 ml of DME containing 20% FCS and 200 OCi of 5"Cr-sodium chromate (New England Nuclear). Normal alveolar macrophages were lavaged from healthy rats and plated in tissue culture plates (1 X 105 cells/well) which had been precoated with normal rat IgG (100 pg/ml x 60 min), in order to ensure firm adherence of the macrophages.
After 1 h, the macrophages were gently washed with HBSS to remove nonadherent cells. We have reported previously that > 95% of macrophages are adherent after this wash (62) . 5"Cr-P. carinii (1 X 106) containing surface-associated SP-D were added to the macrophages and incubated at 370C for an additional hour. Subsequently, nonadherent P. carinii were removed by washing. The macrophage monolayers containing adherent P. carinii were solubilized in 1 N NaOH and quantified. Adherence of P. carinii was defined as: percentage of adherence = (A/ A + B) x 100, where A = 5'Cr-P. carinii associated with the monolayer, and B = unattached 5'Cr-P. carinii. To assess the effect of SP-D on the attachment of P. carini to alveolar macrophage lung cells in culture, P. carinii adherence assays were conducted in the presence of nonimmune rabbit IgG (100 Ag/ml), a polyclonal rabbit antibody generated against SP-D (100 Ag/ml), or SP-D (5 [g/ml).
As a second method to evaluate SP-D-mediated binding of P. carinii to macrophages, we used specific sugars to dissociate SP-D from the surface of freshly isolated P. carinii. Interactions of SP-D with glycoconjugates are preferentially inhibited by maltose, but can also be inhibited by glucose and mannose, the principal sugar constituents of gpA (9, 22, 34) . In contrast, lactose is a much less effective inhibitor of SP-D interactions (21, 22, 24) . Accordingly, freshly isolated P. carinii were incubated with either maltose, mannose, or lactose (100 mM) or in TBS containing 1 mM calcium alone (control) for 1 h. Subsequently, the organisms were washed and collected by centrifugation (1,400 g X 5 min). SP-D released into the supernatants was assessed with immunoblotting. The recovered organisms were additionally labeled with 51Cr and assayed for their ability to adhere to alveolar macrophages.
Immunoprecipitation. Immunoprecipitation experiments were performed to determine whether the polyclonal antibody to SP-D might also crossreact with macrophage mannose receptors, another C-type lectin. Alveolar macrophages (12 x 106) were isolated from uninfected rats by lavage, starved in methionine-free RPMI medium containing 10% FBS for 1 h, and incubated with 35S-Trans label (250 GCi; New England Nuclear) in 5 ml methionine-free RPMI containing 10% FBS overnight at 370C. The cells were washed, disrupted by repeated freezethaw cycles, and sonicated in 50 mM Tris buffer (pH 7.4) containing 1 mM leupeptin and 1 mM pepstatin. Membrane-associated proteins were recovered by centrifugation at 100,000 g for 30 min and solubilized in PBS containing 1% Triton X-100 and 1 mM calcium and magnesium. Radiolabeled macrophage protein extracts were divided into equal aliquots, preabsorbed with protein A-Sepharose, and parallel 50-sLI aliquots were incubated with either anti-SP-D or with nonimmune rabbit IgG (100 ,ug/ml). Protein-antibody complexes were precipitated using protein A-Sepharose, eluted with 1% SDS containing 5% /3-mercaptoethanol, and analyzed by SDS-PAGE as described previously (63) . As a positive control, radiolabeled macrophage proteins were also immunoprecipitated using a polyclonal goat anti-mannose receptor antiserum, generously provided by Dr. Philip Stahl, or with nonimmune goat serum (52) . For conditions using goat serum, protein G-Sepharose was substituted for protein A-Sepharose in an identical fashion.
Effect of SP-D on macrophage phagocytosis of P. carinii. To determine whether SP-D also mediates phagocytosis of P. carinii, radiolabeled P. carinii were allowed to bind to macrophages in the presence or absence of adenosine and homocysteine thiolactone, which are potent inhibitors of macrophage phagocytosis (64) . P. carinii were radiolabeled with 5'Cr and incubated with alveolar macrophages for 2 h in the presence or absence of adenosine (100 AM) and homocysteine thiolactone (250 MM). Nonbound organisms were removed by washing, and the cells were lysed in 1 N NaOH and quantified. The number of cpms associated with macrophages in the absence of inhibitors represents both bound and internalized P. carini organisms. In contrast, the number of cpms associated with macrophages in the presence of adenosine and homocysteine thiolactone represents only bound P. carinii. The difference between these two determinations provides an estimate of phagocytosis. To evaluate the role of SP-D in binding and phagocytosis of P. carinii by macrophages, we compared the interaction of freshly isolated P. carinii, EDTA-treated organisms, and EDTA-treated P. carinii with additional SP-D. As an independent confirmation of the effectiveness of these agents in impairing phagocytosis, we and others have observed previously that adenosine and homocysteine thiolactone effectively inhibit the phagocytosis of opsonized zymosan particles by alveolar macrophages using the luminol-dependent chemiluminescence method (61) .
Role of mannose receptors in P. carinii adherence to alveolar macrophages. To investigate the potential role of mannose receptors in mediating the SP-D-dependent adherence of P. carinii to alveolar macrophages, we further assayed P. carinii binding to macrophages in the presence of yeast a-mannan. Yeast a-mannan is an effective soluble inhibitor of macrophage mannose receptors (65, 66). Fresh untreated and EDTA-treated P. carinii were radiolabeled with 51Cr as described.
Alveolar macrophages were incubated with a-mannan (100 jig/ml) for 20 min before the addition of radiolabeled 5"Cr-labeled P. carinii with or without additional SP-D (5 /ig/ml) and throughout a subsequent 60-min incubation. Unattached P. carinii were removed by washing, and the percentage of organisms adherent to the macrophage cell layers was determined by gamma counting.
Statistical methods. Data are expressed as mean±SEM from multiple experiments. Differences between multiple data groups were first assessed using one-way ANOVA. Subsequently, individual treatment groups were compared using t tests with Bonferroni's correction for multiple comparisons. Differences between paired experimental data were assessed with Student's t test for normal parameters and with the Mann-Whitney U test for nonparametric data. Statistical testing was performed using Statview (Fig. 3) . Rats were immunosuppressed with dexamethasone and inoculated with P. carinii. Since corticosteroid treatment itself is known to increase expression of surfactant components, control rats were also immunosuppressed with dexamethasone, but in addition received trimethoprim/sulfamethoxazole prophylaxis to prevent development of pneumonia. No (Fig. 4, lane A) . Incuba SP-D enhances the interaction of P. carinii with alveolar macrophages. After demonstrating that SP-D is bound to freshly isolated P. carinii, we next sought to determine whether SP-D modulates the adherence of P. carinii to macrophages (Fig. 7) . Freshly isolated P. carinii possessing surface-associated SP-D were radiolabeled with 51Cr and permitted to bind to alveolar macrophages in the presence of no added antibody, or with antibody to SP-D or nonimmune immunoglobulins. Incubation of the radiolabeled P. carinii with surface-associated SP-D in the presence of antibody recognizing SP-D resulted in significant reduction in P. carinii adherence to macrophages (asterisk in Fig. 7 denotes P = 0.0004 compared with control). In contrast, incubation in the presence of nonimmune immunoglobulin did not alter adherence of the radiolabeled P. carinii to macrophages. To further confirm the specificity of the anti-SP-D antibody in these studies, parallel assays were performed in which P. carinii binding was evaluated in the presence of both anti-SP-D and purified SP-D (5 jig/ml) (Fig. 7) . Addition of SP-D resulted in neutralization of the antibody, and P. carinii adherence was returned to control levels. Of interest, the addition of purified SP-D alone (5 jig/ml) resulted in little change in organism adherence to macrophages.
Since SP-D shares sequence homology with other C-type lectins, it is possible that the polyclonal antibodies recognizing SP-D may also crossreact with macrophage mannose receptors, another C-type lectin. Recent studies indicate that macrophage mannose receptors can mediate P. carinii uptake (65, 66 (Fig. 9) . The carbohydrate recognition domain of SP-D exhibits preferential recognition of maltose (34, 58) . Consistent with this, maltose caused substantial dissociation of SP-D from the organisms. Maltose treatment also resulted in a significant decrease in organism adherence to macrophages (P = 0.02). Mannose, which represents the major sugar constituent of gpA, and a known competitor of SP-D binding, also dissociated SP-D from P. carinii and reduced organism binding to macrophages (P = 0.03). In contrast, lactose did not significantly dissociate SP-D from the organism and had little effect on P. carinii adherence. Thus, the specific removal of SP-D from the P. carinii is associated with reduction in P. carinji adherence to alveolar macrophages. 2704 O'Riordan et al. with 20 mM EDTA and washed before radiolabeling to remove as much surface-associated SP-D as possible (Fig. 10) . In addition, EDTA treatment also removes other adhesive proteins including vitronectin, fibronectin, and SP-A from the organisms. Treatment of organisms with EDTA resulted in a significant reduction of the net binding of P. carinii to alveolar macrophages (17.1±2.4% of unstripped controls; P = 0.0001 compared with untreated controls). The addition of SP-D to EDTAtreated P. carinii caused a significant increase in organism adherence to macrophages (52.1±6.1% of control; P = 0.001 comparing adherent EDTA-treated organisms with and without SP-D). Taken together, these data strongly indicate that SP-D associated with P. carinii significantly augments binding of organisms to macrophages.
Role of SP-D in P. carinii phagocytosis. Having observed that SP-D augments the interaction of P. carinii with macrophages, we next sought to determine whether SP-D functions as an opsonin. By definition, an opsonin enhances both the binding and phagocytosis of the organisms. To study this, we compared the interaction of macrophages with freshly isolated P. carinii, EDTA-treated organisms, and EDTA-treated P. carinii with added SP-D (5 ug/ml). Parallel studies were performed in the presence or absence of phagocytosis inhibitors (Fig. 10) . We observed that freshly isolated P. catinii are both bound and phagocytized. Adenosine and homocysteine thiolactone significantly decreased the amount of radiolabeled P. carinii associated with macrophages, indicating -56. 1+4.8% of organisms A B C D E were phagocytized during these assays (P = 0.0003 comparing freshly isolated P. carinii in the presence and absence of phagocytosis inhibitors). Treatment of the organisms with EDTA decreased P. carinii interaction with macrophages, and the reinstitution of SP-D significantly enhanced P. carinii binding. Of interest, however, SP-D did not result in significant potentiation of P. carinii phagocytosis (P = 0.07 comparing the interaction of EDTA-treated P. carinii and added SP-D with macrophages in the presence and absence of inhibitors). These data indicate that, although SP-D promotes the binding of P. carinii to macrophages, it does not act as a potent opsonin for organism uptake.
Role ofmannose receptors in P. carinii adherence to alveolar macrophages. Recent Figure 7 . Role of SP-D in the adherence of P. carinii to alveolar macrophages. 51Cr-labeled P. carinii were permitted to bind to confluent monolayers of alveolar macrophages plated on nonimmune IgG over 1 h in DME containing BSA (1 mg/ml) in the presence of no additional SP-D or antibody (Control) or in the presence of nonimmune IgG (100 Mg/ ml) or with the polyclonal antibody recognizing SP-D (100 Mg/ml). The specific antibody to SP-D but not the nonimmune IgG resulted in significant reduction in P. carinii adherence to macrophages (*P = 0.0004 compared with control). To further assess the specificity of this antibody interaction in parallel assays, binding was studied in the presence of (50, 63) . Interestingly, however, the SP-D-mediated adherence of P. carinji to macrophages was not significantly inhibited by a-mannan, suggesting that mannose receptors do not actively participate in this pathway of organism adherence to macrophages.
Additional studies reveal that other glycoproteins present in the lower respiratory tract also modulate the interaction of P. carindi with lung cells. In particular, the adhesive glycoprotein fibronectin has been implicated in P. carindi attachment to cultured lung epithelial cells and macrophages (49, 61) . Interestingly, like SP-D, fibronectin enhances the attachment of P. carinii to alveolar macrophages, but does not augment phagocytosis of the organisms (61) . Similarly, vitronectin also bind to P. carinji and mediates adherence of the organisms to lung epithelial cells (55) . Both vitronectin and fibronectin are increased in the lower respiratory tract during P. carini pneumonia (10, 11). To minimize the effect of other glycoproteins during P. carinii binding to macrophages, we treated the organisms with EDTA and assessed their ability to interact with macrophages in the presence of added SP-D. Under these conditions, SP-D significantly increased organism adherence to the macrophages. It should also be noted, however, that SP-D did not totally compensate for the reduction in organism binding resulting from EDTA treatment, thus indicating that the removal of other proteins including vitronectin, fibronectin, and SP-A may also decrease organism binding to macrophages.
These multiple receptor-ligand interactions make it difficult to study the role of one protein such as SP-D in the binding of P. carini with macrophages. Accordingly, we have taken several approaches to address the potential role of SP-D in this interaction. These approaches have included antibody neutralization of SP-D, specific removal of SP-D with maltose, general removal of adhesion proteins (SP-D, SP-A, fibronectin, and vitronectin) with EDTA, and the readdition of SP-D to EDTAstripped organisms. These data taken together strongly support a role of SP-D in the interaction of P. carinji with alveolar macrophages. It remains possible, however, that some of reported effects of SP-D, such as the observed lack of effect of exogenous SP-D on the adherence of unstripped P. carinii to macrophages (Fig. 7) , may also be related to the presence of other adhesive proteins on these freshly isolated organisms.
Some studies show that alveolar macrophages bind, phagocytize, and degrade P. carinii and are activated to release reactive oxidants, eicosanoids, and cytokines in response to the organism (14, 15, (66) (67) (68) (69) (70) (71) (72) (73) (74) (75) . A number of potential mechanisms exist by which SP-D can increase binding without augmenting phagocytosis. For instance, SP-D may act to mask gpA on the surface of P. carindi, thus impairing phagocytosis through macrophage mannose receptors. In addition1>SP-D is known to aggregate microorganisms in vivo (34) . Aggregates or clusters of organisms are characteristically observed in tissues and BAL obtained from patients with P. carinji pneumonia (7) . While aggregation of P. carinji may promote adherence to epithelial surfaces or macrophages, large clusters of organisms may pose greater difficulty for phagocytosis and clearance.
In summary, our investigation demonstrates that SP-D, a surfactant-associated protein, is present in enhanced quantities in the lung during P. carinji pneumonia. SP-D binds to the mannose-rich antigen gpA present on the surface of the organism. Furthermore, the interaction of SP-D with P. carinii gpA modulates interaction of the organism with alveolar macrophages. Additional investigations will be required to fully determine the net benefit of SP-D for the organism and the host during P. carinii pneumonia.
